Innovation vs. quality control: an 'unpublishable' clinical trial of
supplemental ascorbate in incurable cancer.
Cameron E; Campbell A
Med Hypotheses 1991 Nov;36(3):185-9
A computerized data bank was created recording the details of all cancer
patients attending three district general hospitals in West Central Scotland
over a 4.5 year period 1978-1982. At the conclusion of the trial, the
records of 2804 individual patients were available for study, of whom
1826 had reached an incurable stage. 294 of these incurable cancer patients
had received supplemental ascorbate at some stage in their illness, whereas
1532 had not, and served as controls. Analysis showed that the ascorbate-supplemented
patients had a median overall survival time (343 days) almost double that
of the controls (180 days). Our difficulties in having this simple, but
important, observation published are briefly recounted in the introduction.